Inventor
WANG HUAMAO
CN20 patents
⚠️ This page may combine multiple inventors who share the name “WANG HUAMAO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CRAGE MEDICAL CO LTD
9 patentsUS11525006B2Dec 13, 2022
BCMA-targeting antibody and use thereof
CRAGE MEDICAL CO LTD6 citations74
US12435119B2Oct 7, 2025
Genetically engineered cell and application thereof
CRAGE MEDICAL CO LTD0 citations62
US12168061B2Dec 17, 2024
Antibody against glypican-3 and application thereof
CRAGE MEDICAL CO LTD0 citations62
US12534532B2Jan 27, 2026
CLL1-targeting antibody and application thereof
CRAGE MEDICAL CO LTD0 citations61
US12186343B2Jan 7, 2025
Method and composition for treating tumors
CRAGE MEDICAL CO LTD0 citations61
US11596653B2Mar 7, 2023
Compositions and methods of cellular immunotherapy
CRAGE MEDICAL CO LTD0 citations61
US12098199B2Sep 24, 2024
Immunologic effector cell of targeted CLD18A2, and preparation method and use thereof
CRAGE MEDICAL CO LTD0 citations60
US11453860B2Sep 27, 2022
GPC3 and ASGPR1 double-targeted transgenic immune effector cell and use thereof
CRAGE MEDICAL CO LTD0 citations54
US11530270B2Dec 20, 2022
Antibody targeting IL-13RA2 and use thereof
CRAGE MEDICAL CO LTD0 citations51
CARSGEN THERAPEUTICS CO LTD
3 patentsUS10793641B2Oct 6, 2020
Fully human anti-mesothelin antibodies and immune effector cells targeting mesothelin
CARSGEN THERAPEUTICS CO LTD5 citations71
US10023639B2Jul 17, 2018
Multi-functional antibody polypeptide for cryptic epitope of epidermal growth factor receptor and T cell antigen
CARSGEN THERAPEUTICS CO LTD6 citations67
US10927176B2Feb 23, 2021
Tumor-specific anti-EGFR antibody and application thereof
CARSGEN THERAPEUTICS CO LTD0 citations50